Search results
India to manufacture medication for diabetes, obesity under PLI by 2026: Report
Firstpost· 4 days agoThe patent on semaglutide, a GLP-1 agonist and the main component of the immensely successful...
The patent on semaglutide, a GLP-1 agonist and the main component of the immensely successful...